MedicarePartD.guide

A non-government resource built from CMS public data

Fetzima on Blue Cross MedicareRx Basic (S5715-012)

levomilnacipran hydrochloride

Covered.

Tier 4 (non-preferred drug). Quantity limit of 30 per 30 days.

$240.93
Patient pays / month, after deductible
$560.30
Patient pays / month, before the $615.00 deductible
$722.79
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

FETZIMA 20 mg Capsule, Extended Release at a preferred retail pharmacy, from the plan's negotiated price of $560.30 for a month. Other covered strengths are listed below.

All 5 covered strengths and forms
FormTierPatient pays / monthLimits
FETZIMA 120 mg Capsule, Extended Release4$242.0630 per 30 days
FETZIMA 20 mg Capsule, Extended Release4$240.9330 per 30 days
FETZIMA 40 mg Capsule, Extended Release4$243.5930 per 30 days
FETZIMA 80 mg Capsule, Extended Release4$241.6430 per 30 days
FETZIMA Kit4$248.5528 per 28 days

Verify with the plan before prescribing or filling. Member services: (888)285-2249. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5715-012